Evidence map›Paper›PMID 25186055›Full record

SynthesisJournal of human genetics2014

GST Theta null genotype is associated with an increased risk for ulcerative colitis: a case-control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel disease.

Mark M T J Broekman, Caro Bos, René H M Te Morsche, Frank Hoentjen, Hennie M J Roelofs, Wilbert H M Peters, Geert J A Wanten, Dirk J de Jong

Open access · bronzeAbstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mark M T J BroekmanDepartment of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
Caro BosDepartment of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
René H M Te MorscheDepartment of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
Frank HoentjenDepartment of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
Hennie M J RoelofsDepartment of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
Wilbert H M PetersDepartment of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
Geert J A WantenDepartment of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
Dirk J de JongDepartment of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutathione S-transferases (GSTs) are important in the detoxification of many compounds, including reactive oxygen species. Polymorphisms in GSTs resulting in a decreased enzyme activity might enhance the risk for inflammatory bowel disease by eliciting a state of oxidative stress. Previous case-control studies showed divergent results and were frequently limited in sample size; therefore we conducted a meta-analysis including results from our case-control study. For the case-control study, we genotyped 552 patients with Crohn's disease (CD), 223 patients with ulcerative colitis (UC) and 972 healthy controls by PCR for functional deletions in GST Mu and GST Theta. Both were not analyzed in recent genome-wide association studies. For the meta-analysis, PubMed, EMBASE and Web of Science were searched. In this meta-analysis, we show an enhanced susceptibility for UC in individuals with the GSTT1null genotype (odds ratio (OR) 2.27, 95% confidence interval (CI) 1.31-3.92). In our case-control study, a reduced risk for CD was seen with the GSTT1null genotype (OR 0.58, 95% CI 0.43-0.77); however, pooled analysis showed an OR of 1.67, 95% CI 0.81-3.45. In this meta-analysis, we showed an increased risk for UC in individuals with the GSTT1null genotype.

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticAdultCase-Control StudiesColitis, UlcerativeCrohn DiseaseGlutathione TransferaseHumansMiddle AgedOdds RatioRiskglutathione S-transferase T1Glutathione Transferase

Identifiers

PMID25186055
OpenAlexW1979658180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.